TELA Bio and Intrusion Inc. Lead Q4 2025 Earnings in MedTech and Cybersecurity
TELA Bio and Intrusion Inc. reported their Q4 and full-year 2025 financial results, highlighting growth in soft tissue reconstruction and advanced cybersecurity solutions. These reports, alongside a leadership transition at Reed's Inc., underscore the evolving landscape of medical technology and data protection in the healthcare sector.